Glucotrack Seeks Shareholder Nod for $50M Equity Line and $7.95M Bridge Note Conversion, Potential Dilution Exceeds 90%
GCTK sits 60% above its 52-week low of $0.25 on light trading volume (0.1× avg).
Summary
Glucotrack's definitive proxy for a September 11 special meeting seeks approval for a $50M equity line and conversion of $7.95M in bridge notes, with potential dilution exceeding 90% of the current share count.
Key Events · Financing and Capital Events · GCTK
-
Shareholder Vote on $50M ELOC
Proposal 1 seeks approval to issue shares to White Lion Capital under a $50M equity line, including 2.5M commitment shares and a $10M commitment warrant, at prices as low as 97% of VWAP.
-
Bridge Financing Upsized to $7.95M
Proposal 2 covers conversion of $7.95M in bridge notes (up from $4.45M) and exercise of related warrants. Conversion floor price is $0.079824, implying ~89M shares on conversion and ~160M on warrants — over 20x current outstanding.
-
Extreme Dilution Risk
If both proposals pass and are fully utilized, total shares could exceed 250M vs. 10.6M outstanding, diluting existing holders by over 90%. The bridge conversion price is 80% below the current $0.40 stock price.
-
Liquidated Damages for Delay
Failure to obtain approvals triggers penalties: $50K/month for the ELOC and $250K/month in stock (or cash) for the bridge, with mandatory additional shareholder meetings every 60-90 days.
Analysis · GCTK · Industrial Applications And Services
Glucotrack is asking shareholders to approve two deeply dilutive financing deals that together could increase shares outstanding by over 20-fold. The $50 million ELOC with White Lion Capital lets the company sell stock at a discount to market, while the $7.95 million bridge notes convert at a floor price of just $0.08 — far below the current $0.40 stock price. If fully converted and exercised, the bridge alone could issue roughly 89 million shares on conversion and 160 million on warrants, against only 10.6 million shares outstanding today. The company is already under a going-concern warning and facing Nasdaq delisting; failure to get these approvals triggers escalating cash penalties. This vote is effectively a choice between extreme dilution and potential insolvency.
At the time of this filing, GCTK was trading at $0.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.1M. The 52-week trading range was $0.25 to $14.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.